These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2203166)

  • 1. [Occult carcinoma in urology. Nosography and diagnosis].
    Alberti C; Sacchini P; Cortellini P
    Minerva Urol Nefrol; 1990; 42(2):85-93. PubMed ID: 2203166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastases with CUP syndrome].
    Seeber S; Strumberg D
    Urologe A; 2006 May; 45(5):614-9. PubMed ID: 16710679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.
    Gamble AR; Bell JA; Ronan JE; Pearson D; Ellis IO
    BMJ; 1993 Jan; 306(6873):295-8. PubMed ID: 8461645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
    Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
    Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoma of unknown primary site: From necropsy to epigenetic analysis].
    Penel N
    Bull Cancer; 2017 Feb; 104(2):112-113. PubMed ID: 27912891
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibody immunophenotyping of solitary cerebral metastases with unknown primary sites.
    Clark WC; Nicoll JA; Coakham H
    Br J Neurosurg; 1989; 3(5):591-5. PubMed ID: 2818851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
    Fülöp M; Kásler M; Remenár E; Lengyel Z; Borbély K
    Magy Onkol; 2012 May; 56(2):84-92. PubMed ID: 22629545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo Kuribreña JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics-a rare and ubiquitous histotype.
    Guadagno E; De Rosa G; Del Basso De Caro M
    J Clin Pathol; 2016 Jul; 69(7):563-74. PubMed ID: 26915369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical symptoms in patients with germinal testicular tumors].
    Dieckmann KP; Krain J; Gottschalk W; Büttner P
    Urologe A; 1994 Jul; 33(4):325-30. PubMed ID: 7524231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction to the problem of markers in urologic oncology].
    Base J
    Rozhl Chir; 1990 Nov; 69(11):750-3. PubMed ID: 2136439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies in urology: review of reactivities and applications in diagnosis, staging, and therapy.
    Vessella RL; Chiou RK; Lange PH
    Semin Urol; 1985 May; 3(2):158-67. PubMed ID: 3916560
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigens associated with epithelial ovarian carcinomas.
    Bast RC
    Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic management of inaugurable metastases].
    Penel N
    Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
    Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
    Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of carcinoma origin by thyroid transcription factor-1 immunostaining of fine needle aspirates of metastases.
    Strojan Flezar M; Srebotnik Kirbis I
    Cytopathology; 2009 Jun; 20(3):176-82. PubMed ID: 18373697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Space-occupying lesions in the liver: incidence of adenocarcinoma metastases of unknown primary site].
    Eickhoff A; Spiethoff A; Hartmann D; Jakobs R; Weickert U; Schilling D; Eickhoff JC; Bohrer MH; Riemann JF
    Dtsch Med Wochenschr; 2007 Feb; 132(8):369-74. PubMed ID: 17299675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.